Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Minarowski, A. Minarowska, D. Sands, M. Knas, S. Szajda, A. Karwowska, M. Gacko (Bialystok, Warsaw, Poland). The activity of selected proteolytic enzymes in saliva of cystic fibrosis patients. Eur Respir J 2009; 34: Suppl. 53, 471

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract: The activity of selected salivary proteases and glycosidases in whole saliva of cystic fibrosis patients Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Dysregulation of the expression and activity of antimicrobial peptides in COPD and cystic fibrosis Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung Year: 2018 Clinical status and activity of lysosomal carboxypeptidase A and cathepsin D in mixed saliva of cystic fibrosis patients Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008 Neutrophil functional activity of patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008 Neutrophil functional activity of patients with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 Characteristics of the composition and level of cell-free DNA and nuclease activity in patients with cystic fibrosis Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Serum bactericidal activity in non cystic fibrosis bronchiectasis in patients with pseudomonas aeruginosa colonisation Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Inhibition of airway proteases in cystic fibrosis lung disease Source: Eur Respir J 2008; 32: 783-795 Year: 2008 Definition of trypsin-like enzymes activity as the marker of severity of idiopathic pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 Decreased levels of secretory leucoprotease inhibitor in the pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition Source: Eur Respir J 2011; 37: 1083-1090 Year: 2011 The role of matrix metalloproteinases in cystic fibrosis lung disease Source: Eur Respir J 2011; 38: 721-727 Year: 2011 Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis Source: Eur Respir J, 51 (3) 1701910; 10.1183/13993003.01910-2017 Year: 2018 The identification of bacterial strains in specimens of adult cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004 Comparison of different techniques to evaluate active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 The role of antimicrobial peptides in cystic fibrosis in childhood. Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Enzymatic activity and clinical parameters in non-cystic fibrosis bronchiectasis: A cohort analysis Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Sputum and plasma neutrophil elastase in stable adult patients with cystic fibrosis in relation to chronic Pseudomonas colonization. Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 The markers of inflammatory process activity and fybrogenesis activity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010